COPPELL, Texas--(BUSINESS WIRE)--Jul. 6, 2016--
Mannatech®,
Incorporated (NASDAQ: MTEX), a global health and wellness company
committed to transforming lives to make a better world, today announced
the appointment of David Ori, a direct sales industry veteran, to the
position of Vice President of EMEA. In this position, Ori will be
responsible for expanding the company’s European, Middle East and
African markets, strengthening international business efforts and
supporting Mannatech’s independent sales Associates in this region.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160706005206/en/
Mannatech's Vice President of EMEA, David Ori (Photo: Business Wire)
Ori’s hiring is in line with Mannatech’s strategy for building and
strengthening its global leadership as it continues to expand its
international operations and align its foreign markets with cohesive
direction, purpose and ambitious objectives.
“David’s experience in the direct sales industry and international
markets will help us create effective strategies for rapid global
expansion while providing unique insights into addressing Associate
needs,” said Alfredo “Al” Bala, Mannatech’s CEO and President. “He will
be instrumental in helping us lead and grow our operations in those
regions, and his valuable work experience will enable us to better serve
our Associates.”
Ori joins Mannatech with more than 20 years of experience within the
direct selling industry as well as international market expertise. Prior
to joining Mannatech, Ori served as vice president of international
development for Youngevity International, where he was responsible for
leading the global expansion team, building international infrastructure
and managing a global team in several regions.
He has also held several other positions including vice president of
international expansion and general manager of China, Hong Kong and
Taiwan for Isagenix International. Ori has worked for other direct
selling companies including Nikken and Tupperware. He earned a
bachelor’s degree in business administration from Suffolk University,
and in addition to English, he speaks Hebrew and Arabic.
To begin transforming your life or the lives of those around you, please
visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, offers a profound wellness experience through a
financially rewarding opportunity that makes a difference in the lives
of people across the world. Through its innovative glyconutrition
products*, Mannatech transforms lives, providing an unprecedented level
of natural wellness, freedom and purpose.* With more than 20 years of
experience and operations in more than 25 countries, Mannatech is
committed to transforming lives. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
* These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat, cure
or prevent any disease.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160706005206/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com